xpedx®, a business-to-business distribution company in North America, continues to increase its service to healthcare facilities with ICNet NGthe next generation of infection control, surveillance and reporting software.
ICNet is a predictive program that helps identify potential healthcare-associated infections (HAIs) and reduces clerical reporting time, allowing for increased and improved clinical service. Used in more than 1,000 hospitals globally, ICNet conforms to the full complement of patient safety surveillance metrics from the Centers for Disease Control and Prevention (CDC), and is certified for Meaningful Use by the U.S. Government Office of the National Coordinator for Health Information Technology (ONC) to ensure maximum reimbursements from Medicare.
xpedx Healthcare Facility Advisors will be introducing ICNet as a tool that hospitals can use to better understand why HAIs occur in their buildings and break the chain of infection, says Michael Parks, director of marketing for facility solutions at xpedx. The goal is to assist with hospital infection control and improve patient safety.
xpedx was a strategic choice for us because it has quality teams with tremendous reach to the facilities that will benefit the most from this system, says Adam Boris, CEO of ICNet Systems, Inc. This software greatly reduces the time spent reporting to the National Healthcare Safety Network (NHSN), providing a key element of value and tremendous return on investment to healthcare facilities.
ICNet is available for use in healthcare facilities of all sizes, ranging from a single community hospital to national networks of hospitals. Additionally, it can integrate disparate electronic medical records systems and serve as a first look at all patients across a network.
Healthcare facilities and infection preventionists interested in ICNet can contact the xpedx Healthcare Facility Advisor in their areas by e-mailing healthyadvisor@xpedx.com.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.